Skip to content
★ Sign in to follow
DM

D. Michael Wilson

Ingevity CorpFMC CorpAlbemarle Corp
Total declarations
72
Companies
3
▲ Purchases (8 ops.)
€906k
▼ Sales (14 ops.)
€7.2M

Latest filing published 06 Feb 2020 for Ingevity Corp, €148k.

Filing timeline

BuySale
D. Michael Wilson

Insider track record

Disclosed buys
8
Disclosed sells
14
Signal history

Closed purchases

Market purchases
8
Positive at T+90
63%
Median T+90
+0.2%

Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 06 Feb 2020 · 2467 days ago · €148k
    +11.1%
    Entry US$66.84 · Close at T+365 US$74.25
  • Filed 05 Aug 2014 · 4478 days ago · €57k
    -15.4%
    Entry US$60.60 · Close at T+365 US$51.24
  • Filed 31 Jan 2014 · 4664 days ago · €237k
    -23.0%
    Entry US$62.23 · Close at T+365 US$47.92

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

D. Michael Wilson: trading record in brief

This profile gathers the share dealings of D. Michael Wilson across 3 companies, led by FMC Corp, Ingevity Corp and Albemarle Corp. We count 72 filings; the first trade dates from 23 February 2006 and the latest from 6 February 2020.

Both buying and selling appear: 8 purchases worth €906k, against 14 sales worth €7.2M. Sales outweigh purchases by €6.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 38 share grants and 12 option exercises. In 2020 alone, the filings show 3 purchases and no sales.

A typical purchase (the median) is worth €79k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 8 purchases with a full 90-day history, the hit rate stands at 63% and the median 90-day move at +0.2%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 6 February 2020, the filings show an open-market purchase worth €148k in Ingevity Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to D. Michael Wilson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations71 total
  • ▲
    President & CEOExecutivesIngevity Corp
    162,922 USD37SEC
    2,573 shares@ US$63.3233.7% of flowCommon StockSEC:0001653477-20-000008:0
    Canonical exit: 6 May 2020 (T+90)
  • ▲
    President & CEOExecutivesIngevity Corp
    110,772 USD36SEC
    1,723 shares@ US$64.2922.9% of flowCommon StockSEC:0001653477-20-000008:1
    Canonical exit: 6 May 2020 (T+90)
  • ▲
    President & CEOExecutivesIngevity Corp
    209,638 USD38SEC
    3,204 shares@ US$65.4343.4% of flowCommon StockSEC:0001653477-20-000008:2
    Canonical exit: 6 May 2020 (T+90)
  • ◆
    President & CEOExecutivesIngevity Corp
    0SEC
    6,054 shares0Common StockSEC:0001653477-19-000061:0
  • ◆
    President & CEOExecutivesIngevity Corp
    322,357 USD23SEC
    2,822 shares@ US$114.235.8% of flowCommon StockSEC:0001653477-19-000045:0
  • ◆
    President & CEOExecutivesIngevity Corp
    176,600 USD22SEC
    1,546 shares@ US$114.233.2% of flowCommon StockSEC:0001653477-19-000045:1
  • ◆
    President & CEOExecutivesIngevity Corp
    146,523 USD22SEC
    1,277 shares@ US$114.742.6% of flowCommon StockSEC:0001653477-19-000045:2
  • ◆
    President & CEOExecutivesIngevity Corp
    0SEC
    70,932 shares0Common StockSEC:0001653477-19-000028:0
  • ◆
    President & CEOExecutivesIngevity Corp
    0SEC
    70,932 shares0Common StockSEC:0001653477-19-000023:0
  • ◆
    President & CEOExecutivesIngevity Corp
    4M USD29SEC
    32,895 shares@ US$117.0769.1% of flowCommon StockSEC:0001653477-19-000028:1
  • ◆
    President & CEOExecutivesIngevity Corp
    600,473 USD23SEC
    5,982 shares@ US$100.3810.1% of flowCommon StockSEC:0001653477-18-000058:0
  • ◆
    President & CEOExecutivesIngevity Corp
    0SEC
    8,260 shares0Common StockSEC:0001653477-18-000013:1
  • ◆
    President & CEOExecutivesIngevity Corp
    231,644 USD22SEC
    2,949 shares@ US$78.553.3% of flowCommon StockSEC:0001653477-18-000013:0
  • ◆
    President & CEOExecutivesIngevity Corp
    400,119 USD23SEC
    6,317 shares@ US$63.345.9% of flowCommon StockSEC:0001653477-17-000062:0
  • ◆
    President & CEOExecutivesIngevity Corp
    111,345 USD22SEC
    2,082 shares@ US$53.481.8% of flowCommon StockSEC:0001653477-17-000025:0
  • ◆
    President & CEOExecutivesIngevity Corp
    0SEC
    10,003 shares0Common StockSEC:0001653477-17-000025:1
  • ◆
    President & CEOExecutivesIngevity Corp
    195,806 USD22SEC
    4,433 shares@ US$44.173.1% of flowCommon StockSEC:0001653477-16-000080:0
  • ◆
    President & CEOExecutivesIngevity Corp
    0SEC
    56,977 shares0Common StockSEC:0001653477-16-000069:0
  • ◇
    Sr VP, Pres Catalyst SolutionsExecutivesAlbemarle Corp
    0SEC
    2,477 shares0Common StockSEC:0000932440-14-000328:0
  • ◆
    Sr VP, Pres Catalyst SolutionsExecutivesAlbemarle Corp
    43,508 USD0SEC
    797 shares@ US$54.59Common StockSEC:0000932440-14-000328:1
  • ▲
    Sr VP,Pres, Catalyst SolutionsExecutivesAlbemarle Corp
    76,213 USD0SEC
    1,250 shares@ US$60.97Common StockSEC:0000932440-14-000285:0
    Canonical exit: 30 Oct 2014 (T+90)
  • ▲
    Sr VP,Pres, Catalyst SolutionsExecutivesAlbemarle Corp
    76,675 USD0SEC
    1,250 shares@ US$61.34Common StockSEC:0000932440-14-000285:1
    Canonical exit: 30 Oct 2014 (T+90)
  • ▲
    Sr VP,Pres, Catalyst SolutionsExecutivesAlbemarle Corp
    77,438 USD0SEC
    1,250 shares@ US$61.95Common StockSEC:0000932440-14-000285:2
    Canonical exit: 30 Oct 2014 (T+90)
  • ▲
    Sr VP,Pres, Catalyst SolutionsExecutivesAlbemarle Corp
    76,125 USD0SEC
    1,250 shares@ US$60.90Common StockSEC:0000932440-14-000285:3
    Canonical exit: 30 Oct 2014 (T+90)
  • ▲
    Sr VP,Pres, Catalyst SolutionsExecutivesAlbemarle Corp
    324,200 USD0SEC
    5,000 shares@ US$64.84Common StockSEC:0000932440-14-000042:0
    Canonical exit: 30 Apr 2014 (T+90)

25 of 71 declarations